GB1213295A - Improvements in therapeutic compositions for topical application - Google Patents

Improvements in therapeutic compositions for topical application

Info

Publication number
GB1213295A
GB1213295A GB7494/68A GB749468A GB1213295A GB 1213295 A GB1213295 A GB 1213295A GB 7494/68 A GB7494/68 A GB 7494/68A GB 749468 A GB749468 A GB 749468A GB 1213295 A GB1213295 A GB 1213295A
Authority
GB
United Kingdom
Prior art keywords
compositions
film
april
medicament
topical application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7494/68A
Inventor
Michael John Groves
John Neville Hague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Pure Drug Co Ltd
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Priority to GB7494/68A priority Critical patent/GB1213295A/en
Priority to US723245A priority patent/US3627871A/en
Priority to NO1592/68A priority patent/NO124623B/no
Priority to NL6805856A priority patent/NL6805856A/xx
Priority to DK189868AA priority patent/DK120859B/en
Priority to DE19681767326 priority patent/DE1767326A1/en
Priority to CH626168A priority patent/CH497897A/en
Priority to FR149588A priority patent/FR7919M/fr
Publication of GB1213295A publication Critical patent/GB1213295A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A61L2300/222—Steroids, e.g. corticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,213,295. Medicated, film-forming compositions. BOOTS PURE DRUG CO. Ltd. 19 April, 1968 [27 April, 1967; 15 Feb., 1968], Nos. 19480/67 and 7494/68. Heading A5B. Pharmaceutical compositions for tropical application comprise a medicament and a fluid, pharmaceutically acceptable carrier comprising an aqueous emulsion of a polyvinylidene chloride having a minimum film-forming temperature of less than 35‹C. which dries to give a flexible, non-tacky, adherent, substantially water-vapour-impermeable film which releases medicament to the underlying surface. The compositions may take the form of creams, liquid sprays and aerosol sprays and may contain buffers, preservatives, opacifyers, viscolisers, suspending agents and humidicants as well as internal and external plasticisers for the polymer. Numerous examples of medicaments are given including anti-inflammatory steroids, antibiotics, antifungal agents, antiseptics and local anaesthetics.
GB7494/68A 1967-04-27 1967-04-27 Improvements in therapeutic compositions for topical application Expired GB1213295A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB7494/68A GB1213295A (en) 1967-04-27 1967-04-27 Improvements in therapeutic compositions for topical application
US723245A US3627871A (en) 1967-04-27 1968-04-22 Therapeutic compositions for topical application
NO1592/68A NO124623B (en) 1967-04-27 1968-04-25
NL6805856A NL6805856A (en) 1967-04-27 1968-04-25
DK189868AA DK120859B (en) 1967-04-27 1968-04-25 A process for the preparation of a medicament composition for topical application and containing a polymer emulsion.
DE19681767326 DE1767326A1 (en) 1967-04-27 1968-04-26 Film-forming ointments
CH626168A CH497897A (en) 1967-04-27 1968-04-26 Pharmaceutical vehicle for external application
FR149588A FR7919M (en) 1967-04-27 1968-04-26

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1948067 1967-04-27
GB7494/68A GB1213295A (en) 1967-04-27 1967-04-27 Improvements in therapeutic compositions for topical application

Publications (1)

Publication Number Publication Date
GB1213295A true GB1213295A (en) 1970-11-25

Family

ID=26241463

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7494/68A Expired GB1213295A (en) 1967-04-27 1967-04-27 Improvements in therapeutic compositions for topical application

Country Status (8)

Country Link
US (1) US3627871A (en)
CH (1) CH497897A (en)
DE (1) DE1767326A1 (en)
DK (1) DK120859B (en)
FR (1) FR7919M (en)
GB (1) GB1213295A (en)
NL (1) NL6805856A (en)
NO (1) NO124623B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2376662A1 (en) * 1977-01-10 1978-08-04 Minnesota Mining & Mfg COMPOSITION FOR VETERINARY USE, BASED ON A POLYMER AND A POLYSACCHARIDE
FR2400890A1 (en) * 1977-08-26 1979-03-23 Shiseido Co Ltd SHADOW COMPOSITION
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4323557A (en) 1979-07-31 1982-04-06 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesive containing iodine
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
GB2134781A (en) * 1983-02-15 1984-08-22 Diomed Dev Ltd Composition for the treatment of stasis leg ulcers
EP0138740A2 (en) * 1983-10-17 1985-04-24 Enquay Pharmaceutical Associates Synthetic resin wound dressing and method of manufacturing

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
SE7713617L (en) * 1977-12-01 1979-06-02 Astra Laekemedel Ab ANTITRANSPIRATIVES
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
FR2518404A1 (en) * 1981-12-23 1983-06-24 Thermogene ANALGESIC COMPOSITION COMPRISING AT LEAST ONE ACUTE NEUTRALIZED ALCOHOLIC PHTHALATE BASED ON PEAT EXTRACTS
US4482533A (en) * 1982-01-11 1984-11-13 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing propranolol
US4758426A (en) * 1987-06-11 1988-07-19 Ramsdell Bruce V Therapeutic toilet solution and method of dispersion
JPH01151516A (en) * 1987-12-08 1989-06-14 Shionogi & Co Ltd External drug compounded with vitamin e
EP0533641A3 (en) * 1991-08-19 1993-06-16 Novis W. Smith Jr. Coating composition for parts
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
MXPA01008719A (en) * 2000-09-06 2002-04-10 Air Products Polymers Lp Polymer emulsion preservation using cationic compounds.
WO2003075968A2 (en) * 2002-03-04 2003-09-18 Georgia Tech Research Corporation Biocompatible hydrophilic films from polymeric mini-emulsions for application to skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628205A (en) * 1950-10-21 1953-02-10 Res Prod Corp Viscous hydrophilic composition and method of making the same
US2693438A (en) * 1951-02-21 1954-11-02 Norwich Pharma Co Preformed, nonadherent films for application to open lesions
US3079299A (en) * 1959-11-16 1963-02-26 Gen Aerosol Corp Self-propelling medicinal ointment composition containing polyethylene and method ofapplication
US3215599A (en) * 1963-07-02 1965-11-02 Warner Lambert Pharmaceutical Process for preparing polymer waxmodified petroleum oil unctuous base
US3485915A (en) * 1966-04-22 1969-12-23 Revlon Thickened hydroxypropyl cellulose compositions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2376662A1 (en) * 1977-01-10 1978-08-04 Minnesota Mining & Mfg COMPOSITION FOR VETERINARY USE, BASED ON A POLYMER AND A POLYSACCHARIDE
FR2400890A1 (en) * 1977-08-26 1979-03-23 Shiseido Co Ltd SHADOW COMPOSITION
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4323557A (en) 1979-07-31 1982-04-06 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesive containing iodine
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
GB2134781A (en) * 1983-02-15 1984-08-22 Diomed Dev Ltd Composition for the treatment of stasis leg ulcers
EP0138740A2 (en) * 1983-10-17 1985-04-24 Enquay Pharmaceutical Associates Synthetic resin wound dressing and method of manufacturing
EP0138740A3 (en) * 1983-10-17 1987-01-07 Enquay Pharmaceutical Associates Synthetic resin wound dressing and method of manufacturing

Also Published As

Publication number Publication date
DK120859B (en) 1971-07-26
US3627871A (en) 1971-12-14
NO124623B (en) 1972-05-15
DE1767326A1 (en) 1971-09-02
FR7919M (en) 1970-05-19
NL6805856A (en) 1968-10-28
CH497897A (en) 1970-10-31

Similar Documents

Publication Publication Date Title
GB1213295A (en) Improvements in therapeutic compositions for topical application
KR950007841A (en) Sustained-release drug formulations containing tramadol salts
KR930007444A (en) Pharmaceutical composition containing 4-biphenylacetic acid (BPAA)
NO923756L (en) OSMOTIC DOSAGE SYSTEM FOR DELIVERY OF LIQUID MEDICINES
AR013506A1 (en) USE OF A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF DISEASES OF PULMONARCHRONIC OBSTRUCTION AND OF A KIT INCLUDING FORMOTEROL OR A SALT OR SOLVATE OF THE SAME AND BUDESONIDE
BE746636A (en) AEROSOL MEDICINE DISPENSER INHALER
GB1464388A (en) Preparations containing microencapsulated substances and process
US4147775A (en) Antiseptic composition
Davis et al. Treatment of creeping eruption with topical thiabendazole
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
US3856954A (en) Topical steroid compositions
GB1481411A (en) Pharmaceutical compositions
GB1202148A (en) Pharmaceutical compositions
GB1276089A (en) Pharmaceutical preparations
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
IE32706L (en) Alpha-carboline derivatives.
GB1125924A (en) Organic bismuth derivative
GB1021070A (en) A new triazolone and a process for its preparation
GB1454389A (en) Nasal decongestants nasal decongestants
GB1072359A (en) Pyrazolone derivatives and pharmaceutical compositions containing them
IE34386B1 (en) Pharmaceutical compositions
GB1174362A (en) Oral Medicants for Haemorrhoids.
GB1310967A (en) Anti-inflammatory compositions
GB817182A (en) Therapeutic compositions containing a tetracycline-sodium hexametaphosphate complex
GB1418019A (en) Antimicrobial compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees